Quantcast

Latest Naloxone Stories

2009-03-02 07:00:00

Highly Statistically Significant Results Achieved at Two Dose Levels with No Reversal of Analgesia SAN CARLOS, Calif., March 2 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced positive topline results today from a Phase 2 double-blind, randomized, placebo-controlled study of NKTR-118 in patients with opioid-induced constipation (OIC). NKTR-118, a peripheral opioid antagonist, is an oral once-a-day investigational drug to treat OIC, the most common and debilitating...

2008-11-12 15:00:26

SOUTH BRUNSWICK, N.J., Nov. 12 /PRNewswire/ -- Tris Pharma, a privately owned, specialty pharmaceutical company, today unveiled a key component in the nation's fight against opioid abuse. Its new drug delivery platform, NoBuse(TM), offers a technology by which companies can deliver effective pain relief or ADHD products that are nearly impervious to abuse. In the United States, narcotic pain relievers have fueled a dangerous epidemic. One in five teens has abused a prescription pain...

8fd22bf91c87f301b821a6e53be04e51
2008-11-05 08:45:00

U.S. researchers reported Tuesday frequent use of a drug that alleviates withdrawal symptoms could help young people undergoing treatment for addiction to heroin or prescription painkillers. The study found young addicts who took Reckitt Benckiser's drug Suboxone for 12 weeks were less likely to abuse drugs during treatment. Researchers found they also stayed in treatment longer than those who underwent short-term detox and counseling. Dr. George Woody of the University of Pennsylvania in...

2008-10-22 09:00:42

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that China Aoxing is honored to co-sponsor the 10th National Conference on Drug Dependence and Sino-US Symposium in Drug Abuse and HIV/HCV Co-Morbidity to be held October 22 and 25, 2008, in Xi'an, China. The conference, under the stewardship of Chinese...

2008-10-21 09:00:54

FARMINGTON, Conn., Oct. 21 /PRNewswire/ -- Launched in September 2006, NAABT.org's (http://www.naabt.org/) free and anonymous online matching system has connected nearly 14,000 addicted patients with physicians certified to prescribe Suboxone for opioid addiction. Less than 2% of US physicians are allowed by law to prescribe this treatment, and those that do have a Congress imposed limit on how many patients they can treat (30 or 100 based on how long they have been certified). Virtually...

2008-10-08 09:00:12

Cortex Pharmaceuticals, a neuroscience company, has reported that top-line data from its second Phase IIa study in opioid-induced respiratory depression demonstrated that a single oral dose of 1500mg of the Ampakine compound CX717 achieved statistical significance over placebo on the primary endpoint measure of spontaneous basal respiration without affecting opioid-induced analgesia. In this placebo-controlled, double-blind, randomized two-way crossover trial (CX717-RD-01), 16 volunteers...

2008-10-06 00:00:36

Hospitalized kids with painful ailments from broken bones to cancer are often dosed with strong, painkilling drugs known as opiates. The medications block pain, but they can have nasty side effects. Constipation, for instance, is one side effect that can cause discomfort -- and even extend a child's hospital stay. "No parent wants their child in the hospital any longer than necessary," said Paul Sharek, MD, MPH, medical director for quality management and chief clinical patient safety...

2008-08-04 09:00:12

Alkermes, Inc. (NASDAQ: ALKS) today announced that its partner, Cilag GmbH International, a subsidiary of Johnson & Johnson, received approval from the Russian Regulatory Authorities to market VIVITROL(R) (naltrexone for extended-release injectable suspension) for the treatment of alcohol dependence in Russia. The product will be manufactured by Alkermes and commercialized by Janssen-Cilag, an affiliate company of Cilag GmbH International. "VIVITROL is the first once-monthly injectable...

2008-06-27 18:02:45

Intervention Treatment announced today that it has launched a suboxone treatment program. The program will be used to increase Intervention Treatment's Global mission of providing Intervention and Treatment resources to those affected by alcohol and drug addiction. According to Dr. Jason Schiffman, Chief Medical Officer for Intervention Treatment, "There is a large, poorly met demand for outpatient, office-based treatment of opiate dependence and the addition of the suboxone treatment program...

2008-06-26 09:02:19

Alkermes, Inc. (NASDAQ: ALKS) today announced the initiation of a phase 3 clinical trial of VIVITROL(R) (naltrexone for extended-release injectable suspension) for the treatment of opioid dependence. The multi-center study is designed to assess the efficacy and safety of VIVITROL in approximately 200 patients diagnosed with opioid dependence. The clinical data from this study will form the basis of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'